Related Experiment Videos
Influenza: diagnosis, management, and prophylaxis
1Leicester Royal Infirmary.
BMJ (Clinical Research Ed.)
|May 21, 1994
Summary
Influenza poses significant health and economic risks, necessitating annual vaccination for high-risk groups. Amantadine offers effective treatment and prevention for influenza A, with new developments in diagnostics, vaccines, and antivirals enhancing control strategies.
Area of Science:
- Virology
- Epidemiology
- Public Health
Background:
- Influenza infections lead to substantial global morbidity, mortality, and economic burdens.
- Annual influenza vaccination is a key public health recommendation for high-risk populations.
- Influenza A virus poses a significant threat during epidemics.
Purpose of the Study:
- To review the impact of influenza and current control measures.
- To highlight the efficacy of amantadine for influenza A.
- To discuss emerging advancements in influenza management.
Main Methods:
- Literature review of influenza epidemiology and control.
- Analysis of amantadine's role in treatment and prophylaxis.
- Overview of recent innovations in diagnostics, vaccines, and therapeutics.
Main Results:
- Amantadine demonstrates effectiveness in treating and preventing influenza A.
- Rapid diagnostic tests improve timely identification of influenza cases.
- Live attenuated vaccines and novel antiviral drugs represent significant advancements.
Conclusions:
- Influenza remains a major public health concern requiring ongoing vaccination efforts.
- Amantadine is a valuable tool for managing influenza A outbreaks.
- Continued research and development in diagnostics, vaccines, and antivirals are crucial for future influenza control.